Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about treatment/resistant depression Recent news which mentions treatment/resistant depression Pharma Giant Johnson & Johnson Asks FDA To Approve Esketamine Nasal Spray For Treatment-Resistant Depression July 23, 2024 Tickers JNJ NEWS Tags News TDR ketamine depression From Benzinga First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression April 26, 2024 Tickers NEWS Tags News BPL/003 5/MeO/DMT From Benzinga Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression March 28, 2024 Tickers ATAI NEWS Tags ATAI Psychedelics Research News From Benzinga Compass Pathways Shows Robust 2023 Year-End Results, Embraces Clinical Milestones For Psilocybin As Depression Treatment February 29, 2024 Tickers CMPS Tags COMP360 psilocybin therapies Management From Benzinga UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center November 15, 2023 Tickers AWKNF CMPS Tags Psychedelics AWKNF treatment/resistant depression From Benzinga Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation October 03, 2023 Tickers ATAI Tags Psychedelics treatment/resistant depression Cannabis From Benzinga Compass Pathways Explores AI-Powered Predictive Model On Psilocybin Therapy For Depression September 06, 2023 Tickers CMPS Tags Cannabis Market News Benzinga From Benzinga GH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026 August 24, 2023 Tickers GHRS Tags 5/MeO/DMT Small Cap treatment/resistant depression From Benzinga Compatibility Of Psilocybin & SSRIs For Depression, COMPASS Looks At 'Psychedelic-Assisted Therapies' July 18, 2023 Tickers CMPS Tags Markets CMPS News From Benzinga COMPASS Pathways Secures Up To $50M In Term Loan Facility With Hercules Capital July 05, 2023 Tickers ATAI CMPS HTGC Tags Cannabis Financing Psychedelics Financing From Benzinga Numinus' Clinical Site Joins Compass' Phase 3 Program On Psilocybin Therapy For TRD May 30, 2023 Tickers CMPS NUMIF Tags Market News Cannabis Psychedelic/Assisted Therapies From Benzinga GH Research: Q1 2023 Financials And Businesses For European 5-MeO-DMT Depression Treatment Developer May 11, 2023 Tickers GHRS Tags Psychedelics treatment/resistant depression Biotech From Benzinga Beckley Psytech Begins Phase IIa Study Of Psychedelic Compound To Treat Depression May 04, 2023 Tags News General BPL/003 From Benzinga Cathie Wood Reacts To Atai's Drastic Stock Plunge After Doomed Clinical Study Results January 12, 2023 Tickers ATAI CMPS IGXT Tags Cathy Wood News CMPS From Benzinga Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far December 12, 2022 Tickers CMPS Tags CMPS News Markets From Benzinga Psychedelics And Treatment-Resistant Depression: COMPASS Pathways Replies To Comments December 09, 2022 Tickers CMPS Tags Market News Cannabis Benzinga From Benzinga Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS' Latest Trial Outcomes November 16, 2022 Tickers CMPS Tags Benzinga Psychedelic/Assisted Therapies Cannabis From Benzinga Psychedelics Company's $60M Series A For Startup To Develop Treatment For Mental Health Disorders November 02, 2022 Tags Markets News Catalent From Benzinga atai's Phase 1 Synthetic DMT-Based Drug Clinical Trial Begins Patient Dosing October 05, 2022 Tickers ATAI Tags DMT Clinical Trial Penny Stocks Benzinga From Benzinga Psilocybin For Anorexia: Learn About Compass' Novel Phase 2 Trial Using Magic Mushroom's Main Compound July 28, 2022 Tickers CMPS Tags Market News Cannabis Global From Benzinga Psilocybin More Effective Than Antidepressants In Treating Depression, New Study Shows April 12, 2022 Tags College London’s Centre for Psychedelic Research Robin Carhart/Harris Benzinga From Benzinga COMPASS Pathways: Positive Psilocybin Trial, High-Dose Group Improves Beyond Depression Reduction December 01, 2021 Tickers CMPS Tags Small Cap Biotech Psilocybin From Benzinga Mike Tyson: How A Drug Derived From Toad Venom Made Him Comfortable With Dying November 16, 2021 Tickers GHRS Tags GHRS MIke Tyson Benzinga From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.